BMO starts Exelixis at Market Perform into patent cliff
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
BMO Capital starts EXEL at Market Perform; Target $54; Current price $53.12.
Target: $54
Posted price: $53.12
Analyst firm: BMO Capital
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.